The Michigan Growth Capital Symposium will showcase 35-40 of the 'Best of the Midwest' high-growth companies in new businesses and emerging technologies. This symposium is expected to bring together over 450 people representing top investment firms from across the U.S. and early stage and emerging growth companies, as well as related stakeholders. Goodwin Procter partner Mitch Bloom will speak on a panel titled "The Return of the Healthcare IPO" with other participants including Tim Mayleben (President and CEO, Esperion Therapeutics), Ted Omlid (Managing Director, Evercore Partners) and Tim Petersen (Managing Director, Arboretum Ventures).
For additional information, please visit: http://michigan-gcs.com/.
Mitchell S. BloomPartnerChair, Life Sciences Practice